# The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

> **NCT01007708** · PHASE3 · COMPLETED · sponsor: **Dow Pharmaceutical Sciences** · enrollment: 780 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** IDP-108
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01007708
- **Lead sponsor:** Dow Pharmaceutical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 780 (ACTUAL)
- **Last updated:** 2012-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01007708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01007708, "The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01007708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*